Associate Conductor of the Richmond Symphony The Richmond Symphony announces that Hae Lee has been named as the Associate ...
Topline results from the pivotal HAELO trial demonstrate that a single infusion of lonvo-z significantly reduces HAE attacks and the need for chronic prophylactic therapy.
Zacks Investment Research on MSN
NTLA falls 4% despite strong phase III HAE data, initiates rolling BLA
Shares of Intellia Therapeutics NTLA declined 4% on Monday despite positive top-line data from the global phase III HAELO ...
KalVista (KALV) to be acquired by Chiesi for $27/share: read why EKTERLY’s HAE growth, pediatric data, and key deal/approval ...
A new analysis of insurance claims data found that fewer than half of hereditary angioedema patients stayed on newer long-term preventive medications after two years. Adherence rates varied across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results